{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:04:09Z","timestamp":1791237849139,"version":"4.1.0"},"reference-count":36,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"4","license":[{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,29]]},"abstract":"<jats:p>Binary file ES_Abstracts_Final_ECDC.txt matches\n<\/jats:p>","DOI":"10.2807\/1560-7917.es2015.20.4.21022","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T16:02:54Z","timestamp":1422633774000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":88,"title":["Interim estimates of 2014\/15 vaccine effectiveness against influenza A(H3N2) from Canada\u2019s Sentinel Physician Surveillance Network, January 2015"],"prefix":"10.2807","volume":"20","author":[{"given":"D M","family":"Skowronski","sequence":"first","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"},{"name":"University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Chambers","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sabaiduc","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"De Serres","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Qu\u00e9bec (University Hospital Centre of Quebec), Qu\u00e9bec, Canada"},{"name":"Laval University, Quebec, Canada"},{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec (National Institute of Health of Quebec), Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Dickinson","sequence":"additional","affiliation":[{"name":"University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Winter","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Drews","sequence":"additional","affiliation":[{"name":"Alberta Provincial Laboratory, Edmonton, Canada"},{"name":"University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fonseca","sequence":"additional","affiliation":[{"name":"University of Calgary, Calgary, Canada"},{"name":"Alberta Provincial Laboratory, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Charest","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec (National Institute of Health of Quebec), Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Gubbay","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Canada"},{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Petric","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Krajden","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Kwindt","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Martineau","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec (National Institute of Health of Quebec), Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Eshaghi","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bastien","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[{"name":"University of Manitoba, Winnipeg, Canada"},{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7995","reference":[{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref01","unstructured":"Public Health Agency of Canada (PHAC). FluWatch. Weekly reports 2014-2015 season. January 11 to January 17, 2015 (week 2). Ottawa: PHAC. [Accessed: 25 Jan 2015]. Available from: http:\/\/www.phac-aspc.gc.ca\/fluwatch\/14-15\/w02_15\/index-eng.php"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref02","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.5.20690"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref03","doi-asserted-by":"crossref","unstructured":"Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter AL, Mahmud SM, et al. Interim estimates of influenza vaccine effectiveness in 2012\/13 from Canada\u2019s sentinel surveillance network, January 2013. Euro Surveill. 2013;18(5):20394. PMID:23399422","DOI":"10.2807\/ese.18.05.20394-en"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref04","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092153"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref05","unstructured":"BC Centre for Disease Control (BCCDC). Influenza surveillance reports: BC influenza surveillance bulletin: Influenza season 2014-15. Report no. 14. Week 2. January 11 to January 17, 2015. Vancouver, BCCDC. [Accessed: 25 Jan 2015]. Available from: http:\/\/www.bccdc.ca\/NR\/rdonlyres\/27E73D7B-55D4-47C0-B2EB-68B94D2618DD\/0\/InfluBulletin_Number14_Week2_201415.pdf"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref06","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu048"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref07","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis431"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref08","unstructured":"World Health Organization (WHO). WHO recommendations on the composition of influenza virus vaccines. Geneva: WHO. [Accessed: 19 Jan 2015]. Available from: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/en\/index.html"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref09","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5446.1921"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009490"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref11","unstructured":"Rambaut A. FigTree v1.4.0, a graphical viewer of phylogenetic trees. Edinburgh: University of Edinburgh. Accessed 19 Jan 2015. Available from: http:\/\/tree.bio.ed.ac.uk\/software\/figtree"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref12","unstructured":"European Centre for Disease Prevention and Control (ECDC). Influenza virus characterisation. Summary Europe, November 2014. Surveillance report. Stockholm: ECDC. 2014. Available from: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ERLI-Net%20report%20November%202014.pdf"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-5773(05)80013-7"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903427106"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041895"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244730"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref17","doi-asserted-by":"publisher","DOI":"10.3390\/v6031294"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref18","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.51"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00458-10"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref20","unstructured":"Centers for Disease Control and Prevention (CDC). FluView. 2014-2015 influenza season week 2 ending January 17, 2015. U.S. Virologic Surveillance, Influenza Virus Characterization. Atlanta: CDC. [Accessed: 25 Jan 2015]. Available from: http:\/\/www.cdc.gov\/flu\/weekly"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref21","unstructured":"Public Health Agency of Canada (PHAC). Vaccine coverage amongst adult Canadians: Results from the 2012 adult National Immunization Coverage (aNIC) survey. Ottawa: PHAC. [Accessed: 19 Jan 2015]. Available from: http:\/\/www.phac-aspc.gc.ca\/im\/nics-enva\/vcac-cvac-eng.php"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref22","unstructured":"Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015;64(1):10-5. PMID:25590680"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref23","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000237829.66310.85"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000237797.14283.cf"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065368"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref26","unstructured":"Advisory Committee on Immunization Practices (ACIP). Grading of recommendations, assessment, development, and evaluation (GRADE) for use of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children. Atlanta: Centers for Disease Control and Prevention. [Accessed: 25 Jan 2015]. Available from: http:\/\/www.cdc.gov\/vaccines\/acip\/recs\/GRADE\/LAIV-child.html"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref27","doi-asserted-by":"crossref","unstructured":"Public Health Agency of Canada. Revised wording to the National Advisory Committee on Immunization (NACI) recommendation for live attenuated influenza vaccine (LAIV) in healthy children and adolescents 2-17 years of age. Canada Commun Dis Rep. 2013;39(ACS-4). [Accessed: 25 Jan 2015]. Available from: http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/13vol39\/acs-dcc-4\/rev-eng.php","DOI":"10.14745\/ccdr.v39i00a04r"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref28","unstructured":"Centers for Disease Control and Prevention (CDC). CDC statement on LAIV effectiveness and vaccination of children. Atlanta: CDC. [Accessed: 25 Jan 2015]. Available from: http:\/\/www.cdc.gov\/flu\/news\/nasal-spray-effectiveness.htm"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref29","doi-asserted-by":"crossref","unstructured":"Castilla J, Martinez-Baz I, Nacascues A, Fernandez-Alonso M, Reina G, Guevara M, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013\/14 mid-season analysis. Euro Surveill. 2014;19(6):pii=20700.","DOI":"10.2807\/1560-7917.ES2014.19.6.20700"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit060"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref31","doi-asserted-by":"crossref","unstructured":"Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the 2012-13 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2014;jiu650. PMID:25416812","DOI":"10.1093\/infdis\/jiu650"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit736"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu680"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.24.14001"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dym021"},{"key":"10.2807\/1560-7917.ES2015.20.4.21022_ref36","doi-asserted-by":"crossref","unstructured":"De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled trials. Euro Surveill. 2013;18(37):20585. PMID:24079398","DOI":"10.2807\/1560-7917.ES2013.18.37.20585"}],"container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T13:59:36Z","timestamp":1663250376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES2015.20.4.21022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,1,29]]}},"URL":"https:\/\/doi.org\/10.2807\/1560-7917.es2015.20.4.21022","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,29]]}}}